Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
10/2008
10/16/2008US20080255223 Treatment and Prevention of Benign Pigmented Moles (Naevi) Using Artemisinine and the Derivatives Thereof
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080254498 Fluorescent ion indicators and their applications
10/15/2008EP1980562A1 Taxol derivatives with antitumor activity
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008CN101287739A Novel fluorine-containing spiroacetal compound and method of producing the same
10/15/2008CN101284836A Rotenone oxime ether, preparation method and applications thereof
10/15/2008CN101284835A Dimeric sesquiterpene lactone compounds, preparation method and applications thereof
10/15/2008CN101284834A Bi-inulicin 1, preparation method and applications thereof
10/15/2008CN101284833A Bi-inulicin 4, preparation method and applications thereof
10/15/2008CN100425612C Fluorescent probe for detecting hydrogen peroxide and its synthesis method and use
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/09/2008WO2008121476A1 Biologically active taxane analogs and methods of treatment by oral administration
10/09/2008WO2008120224A1 A process for the extraction of bioactive lignans with high yield and purity from sesame oil
10/09/2008US20080249323 Aqueous sorbitol to xylitol then isosobide in presence of zeolite acid catalyst and in absence of enzymes; heating, pressurization
10/09/2008US20080249320 Luminacin analogs and uses thereof
10/08/2008EP1352904B1 (meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns
10/08/2008CN101282967A Total synthesis of pladienolide b and pladienolide D
10/08/2008CN101279976A Monitoring method for hot-spot temperature of gas-phase catalytic oxidation reaction in preparation of pyromellitic acid anhydride
10/08/2008CN100424086C Production method of decursin
10/08/2008CN100424062C Process for preparing hydroaromatic polybasic carboxylic acid and process for preparing hydroaromatic polybasic carboxylic anhydride
10/07/2008US7432383 Intermediates for the hemisynthesis of taxanes and preparation processes therefor
10/07/2008CA2335300C Macrocyclic analogs and methods and their use and preparation
10/02/2008WO2008117775A1 Taxanes having oxetane ring structure
10/02/2008WO2008075048A3 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments
10/02/2008WO2008057604A9 Small molecule therapeutics, syntheses of analogues and derivatives and methods of use
10/02/2008US20080242855 Process for Producing Flavone C Glycoside Derivatives
10/02/2008US20080242721 Glycerol Levulinate Ketals and Their Use
10/01/2008EP1973892A1 Novel compounds and methods for forming taxanes and using the same
10/01/2008EP1663934A4 Alpha-hydroxy-benzeneacetic acid derivatives, and compounds having two 5-membered lactone rings fused to central cyclohexa-1,4-diene nucleus based upon the same, and uses of the compounds
10/01/2008CN101277960A Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
10/01/2008CN101274936A Preparation for furocoumarin compound 4 - hydroxy-9-(3,7-dimethylocata-1,6-dien-3-yl)-7H-furo[3,2-g] chromen-7-one and application of the compound
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN100422191C Method for separating and preparing triptolide diol from tripterygium wilfordii
10/01/2008CN100422190C Antitumour compound desacetyl fungus epoxyethyl ester and its preparation method
10/01/2008CN100422189C Taspine alkaline preparation method and uses in preparing medicine for treating tumour
09/2008
09/30/2008US7429670 antagonists of the GlyR (glycine receptor); diterpene trilactones; cage-like skeleton; neuroprotectant, antioxidant, antiproliferation agent, cognition activator; parallel solution phase synthesis
09/25/2008WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/25/2008US20080234502 Epoxidation using a titanium catalyst
09/24/2008EP1972633A1 Antitumour compounds
09/24/2008EP1971608A1 Spiroketals
09/24/2008EP1971588A1 Tiglien-3-one derivatives
09/24/2008EP1387827B1 Synthesis of cyclopentadiene derivatives
09/24/2008CN101270124A Novel method for purifying and preparing high-purity fluorandiol and fluorandiol salt
09/24/2008CN100420690C Benzofuran compound, prepn. method and application thereof
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2173703C Synergistic stabilizer mixture
09/18/2008WO2008111557A1 Process for production of optically active epoxy compound
09/18/2008CA2680425A1 Process for production of optically active epoxy compound
09/17/2008EP1968964A1 Radicicol derivatives useful for positron emission tomography
09/17/2008CN201116298Y Multifunctional continuous oxidation reaction device for producing glucurolactone
09/17/2008CN101265250A Substituted flavonoids and preparation method, application and pharmaceutical composition thereof
09/17/2008CN100418963C Novel herbicides
09/17/2008CN100418958C Taxane derivatives and processes for the preparation thereof
09/16/2008US7425575 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
09/12/2008WO2008075955A3 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles
09/11/2008US20080221207 Use of specific cyklolignans
09/11/2008US20080221140 reverse transcriptase mutants which allow an obligate chain terminating nucleoside- or nucleotide phosphate to be excised from the nascent DNA strand by ATP- or pyrophosphate-mediated excision
09/11/2008US20080221065 Pharmaceutical formulations; epothilone and mannitol or a cyclodextrin parenteral administration in the form of an infusion concentrate or lyophilised composition
09/10/2008EP1967520A2 Production of polyketides and other natural products
09/10/2008EP1966206A1 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
09/10/2008EP1966134A1 Novel fused pyrrole derivatives
09/10/2008EP1312374B1 Primrose seed extracts as sugar absorption inhibitors and process for producing the same
09/04/2008WO2008105896A2 Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
09/04/2008WO2008105495A1 Bis(tetrahydrofuran) compound, method for production of the compound, and use of the compound
09/04/2008WO2008104175A2 Novel phosphodiesterase inhibitors
09/04/2008US20080214648 Hiv Prodrugs Cleavable by Cd26
09/04/2008US20080213439 Distilling a medium containing internal dehydration product to obtain a distillate enriched with this product, purifying; contacting with stabilizing agent; shaping the resulting internal dehydration product of a hydrogenated sugar
09/04/2008CA2676933A1 Novel phosphodiesterase inhibitors
09/04/2008CA2656537A1 Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
09/03/2008EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections
09/03/2008EP1963324A1 Heterocyclic compounds, their preparation and their use as antibacterials
09/03/2008CN101255168A Method for preparing liquid chromatography of monascin and monascus anka flavine pure product
09/03/2008CN101255167A Mixture of diesters of dianhydrohexitol derivatives with carboxylic acids of the empirical formula c8h17cooh, processes for preparing these diesters and use of these mixtures
09/03/2008CN101255166A Preparation of a trans-calanolide ketone intermediate and chiral separation of calanolide alcohols to give racemic calanolide A
09/03/2008CN101255165A Extraction method of dahurian angelica root coumarin
09/03/2008CN101255162A Adenosine receptor antagonists and methods of making and using the same
09/02/2008US7420067 Heating a sugar alcohol in the presence of an acid catalyst, followed by purification such as by vacuum distillation and melt crystallization; organic solvent-free; isosorbide from sorbitol for example
09/02/2008US7420003 Compounds and a novel process for their preparation
09/02/2008US7419993 Triazolo-epothilones
09/02/2008US7419985 reuptake of norephinephrine, dopamine, and serotonin inhibitor; furo-, pyrrolo-, and thienyl-tetrahydroisoquinolines, e.g. 2 methyl 4 phenyl 1,2,3,4,8,9 hexahydro furo[2,3 h]isoquinoline; antidepressant, anxiolytic agent; neurological and psychological disorders
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
08/2008
08/28/2008WO2008102994A1 Composition comprising decursin derivative for treating and preventing atopic dermatitis
08/28/2008WO2008102659A1 Oxidizing agent composition for the epoxidation of olefins and process for the epoxidation of olefins
08/28/2008US20080207747 Lipase Inhibitors
08/28/2008US20080207744 Anticancer agents
08/28/2008US20080207576 Substituted sapogenins and their use
08/27/2008EP1960404A1 Substituted aminophenylsulfonamide compounds as hiv protease inhibitor
08/27/2008EP1959952A2 Chemical synthesis of a highly potent epothilone
08/27/2008EP1751144B1 Constrained himbacine analogs as thrombin receptor antagonists
08/27/2008EP1626974B1 Substituted benzopyrans as selective estrogen receptor-beta agonists
08/27/2008EP1359909B1 Triptolide prodrugs for anti-cancer therapy
08/27/2008CN101250191A Method for preparing 2-phenylamino-6-dibutylamino-3-methyl fluoran
08/27/2008CN101250190A Method for refining pyromellitic anhydride by solvent
08/27/2008CN100413869C Method for ligand chromatography separation purification of bilobalide
08/27/2008CN100413868C Compounds separated from gamboges with activities of inhibiting tumour/cancer cell growth and pharmaceutical compositions containing same
08/27/2008CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
08/26/2008US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 174